Replies to post #8051 on otcbargains undervalued stock board

[Trent Blair]

LPTN That's a interesting stock. I don't invest in biotech without solid revenues like this but people who do will bid them up to net cash or further sometimes. I think you should make a solid profit on this one.

[RNsidersbuying]

LPTN .30 News - with .56 hard cash remaining:

SAN DIEGO, July 23, 2015 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug Application (IND) for Lpathomab™. The FDA informed the company that the Phase 1 clinical trial to study Lpathomab may now be initiated. Lpath plans to begin this trial upon investigational review board approvals and anticipates the first subject to be dosed within two months.

http://ih.advfn.com/p.php?pid=nmona&article=67842617&symbol=LPTN